艾迪药业: 艾迪药业2024年年度股东会决议公告

Meeting Overview - The annual shareholders' meeting of Jiangsu Aidi Pharmaceutical Co., Ltd. was held on May 20, 2025, in Nanjing [1] - A total of 76 ordinary shareholders attended the meeting, representing 204,524,876 voting rights, which accounts for 48.6058% of the company's total voting rights [1] Voting Results - All proposed resolutions were approved during the meeting [2][3] - The voting results for the resolutions included: - 204,327,974 votes in favor (99.9037%), 25,000 votes against (0.0123%), and 171,902 abstentions [1] - 204,331,864 votes in favor (99.9056%), 167,012 votes against (0.0816%), and 26,000 abstentions [2] - 204,211,864 votes in favor (99.8469%), 288,012 votes against (0.1408%), and 25,000 abstentions [1] - 204,339,864 votes in favor (99.9095%), 159,012 votes against (0.0777%), and 26,000 abstentions [2] Legal Compliance - The meeting was convened and conducted in accordance with the Company Law and relevant regulations, ensuring the legality and validity of the resolutions passed [3]